Passage Bio (PASG) Insider Trading & Ownership $0.65 +0.00 (+0.51%) (As of 12/24/2024 05:19 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Passage Bio (NASDAQ:PASG) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.30%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$165,229.88Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$205,723.72 Get PASG Insider Trade Alerts Want to know when executives and insiders are buying or selling Passage Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PASG Insider Buying and Selling by Quarter Ad Brownstone ResearchDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. Passage Bio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/11/2024Orbimed Advisors LlcMajor ShareholderSell80$0.80$64.00 12/9/2024Orbimed Advisors LlcMajor ShareholderSell54,181$0.84$45,512.04 12/6/2024Orbimed Advisors LlcMajor ShareholderSell20,903$0.82$17,140.46 12/4/2024Orbimed Advisors LlcMajor ShareholderSell76,200$0.79$60,198.00 11/27/2024Lynx1 Capital Management LpMajor ShareholderBuy29,300$0.67$19,631.00 11/25/2024Lynx1 Capital Management LpMajor ShareholderBuy259,998$0.56$145,598.88 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/18/2024Orbimed Advisors LlcMajor ShareholderSell25,631$0.73$18,710.63 9/16/2024Orbimed Advisors LlcMajor ShareholderSell63,100$0.74$46,694.00 2/13/2024Kathleen BorthwickCFOSell1,470$0.97$1,425.90 2/13/2024Mark S FormanInsiderSell1,638$0.97$1,588.86 1/2/2024Mark S FormanInsiderSell15,813$0.91$14,389.83 (Data available from 1/1/2013 forward) PASG Insider Trading Activity - Frequently Asked Questions Who is on Passage Bio's Insider Roster? The list of insiders at Passage Bio includes Alexandros Fotopoulos, Bruce A Goldsmith, Kathleen Borthwick, Lynx1 Capital Management Lp, Mark S Forman, Orbimed Advisors Llc, Sandip Kapadia, and Simona King. Learn more on insiders at PASG. What percentage of Passage Bio stock is owned by insiders? 4.30% of Passage Bio stock is owned by insiders. Learn more on PASG's insider holdings. Which Passage Bio insiders have been buying company stock? The following insiders have purchased PASG shares in the last 24 months: Lynx1 Capital Management Lp ($165,229.88), and Orbimed Advisors Llc ($518,600.88). How much insider buying is happening at Passage Bio? Insiders have purchased a total of 906,680 PASG shares in the last 24 months for a total of $683,830.76 bought. Which Passage Bio insiders have been selling company stock? The following insiders have sold PASG shares in the last 24 months: Alexandros Fotopoulos ($3,768.36), Kathleen Borthwick ($1,425.90), Mark S Forman ($15,978.69), Orbimed Advisors Llc ($188,319.13), and Simona King ($12,234.29). How much insider selling is happening at Passage Bio? Insiders have sold a total of 276,574 Passage Bio shares in the last 24 months for a total of $221,726.37 sold. Passage Bio Key ExecutivesDr. William Chou M.D. (Age 50)President, CEO & Director Compensation: $945.73kMr. Edgar B. Cale Esq. (Age 60)J.D., General Counsel & Company Secretary Compensation: $804.69kDr. Mark Forman M.D. (Age 60)Ph.D., Chief Medical Officer Compensation: $866.31kDr. James M. Wilson M.D. (Age 69)Ph.D., Co-Founder & Chief Scientific Advisor Ms. Kathleen Borthwick (Age 47)Senior VP, CFO, Principal Financial Officer & Principal Accounting Officer Mr. Stuart M. HendersonSenior Vice President of Corporate Development & Investor RelationsEden FucciSenior Vice President of Technical OperationsDr. Sue Browne Ph.D.Senior Vice President of Research & DevelopmentDr. Karl Whitney Ph.D.Senior Vice President of Global Regulatory Affairs More Insider Trading Tools from MarketBeat Related Companies TScan Therapeutics Insider Transactions Coherus BioSciences Insider Transactions Zura Bio Insider Transactions Corbus Pharmaceuticals Insider Transactions Sutro Biopharma Insider Transactions Metagenomi Insider Transactions 2seventy bio Insider Transactions Elutia Insider Transactions Sagimet Biosciences Insider Transactions Adaptimmune Therapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:PASG) was last updated on 12/26/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredBuy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Passage Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Passage Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
